Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China flag China · Delayed Price · Currency is CNY
26.27
-0.85 (-3.13%)
Apr 21, 2026, 3:00 PM CST

Aurisco Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,01610,1758,57910,48810,0298,830
Market Cap Growth
32.03%18.61%-18.20%4.58%13.58%38.75%
Enterprise Value
11,01510,1268,31710,0569,7268,296
Last Close Price
27.1225.0520.8225.2123.9621.25
PE Ratio
24.6522.6524.1836.2447.5452.34
Forward PE
19.9416.7318.6930.4739.82-
PS Ratio
6.495.995.818.319.9510.99
PB Ratio
4.153.833.685.335.965.86
P/TBV Ratio
4.414.083.955.686.466.02
P/FCF Ratio
154.23142.46-130.89--
P/OCF Ratio
26.1324.1425.8127.2060.2743.81
EV/Sales Ratio
6.495.975.647.979.6510.33
EV/EBITDA Ratio
16.1815.0217.7828.4935.6135.42
EV/EBIT Ratio
19.8518.2521.5336.0746.7145.40
EV/FCF Ratio
154.22141.77-125.50--
Debt / Equity Ratio
0.360.360.410.060.030.01
Debt / EBITDA Ratio
1.401.402.000.330.190.08
Debt / FCF Ratio
13.3413.34-1.46--
Net Debt / Equity Ratio
00-0.05-0.22-0.20-0.28
Net Debt / EBITDA Ratio
0.000.00-0.26-1.22-1.24-1.82
Net Debt / FCF Ratio
-0.01-0.010.58-5.356.818.70
Asset Turnover
0.420.420.460.550.540.49
Inventory Turnover
1.111.111.151.181.281.45
Quick Ratio
2.672.672.681.691.923.06
Current Ratio
3.953.953.852.733.384.87
Return on Equity (ROE)
18.01%18.01%16.50%15.83%13.05%11.63%
Return on Assets (ROA)
8.56%8.56%7.49%7.56%6.93%7.02%
Return on Invested Capital (ROIC)
18.68%19.76%17.95%16.99%14.85%16.68%
Return on Capital Employed (ROCE)
15.00%15.00%11.60%13.40%12.20%12.00%
Earnings Yield
4.08%4.42%4.14%2.76%2.10%1.91%
FCF Yield
0.65%0.70%-2.42%0.76%-0.50%-0.56%
Dividend Yield
1.05%-1.39%0.87%0.67%0.61%
Payout Ratio
27.63%27.63%26.72%23.15%24.81%28.52%
Buyback Yield / Dilution
-2.44%-2.44%2.21%-0.48%-1.00%-7.31%
Total Shareholder Return
-1.39%-2.44%3.60%0.40%-0.33%-6.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.